Compare Stocks

Date Range: 

 Zimmer BiometColoplast A/SAlign TechnologySTERISSmith & Nephew
SymbolNYSE:ZBHOTCMKTS:CLPBYNASDAQ:ALGNNYSE:STENYSE:SNN
Price Information
Current Price$173.23$16.03$584.72$210.31$43.59
52 Week RangeBuyHoldBuyBuyHold
MarketRank™
Overall Score2.11.01.92.11.9
Analysis Score2.50.02.41.32.2
Community Score2.82.22.82.11.9
Dividend Score1.71.70.03.32.5
Ownership Score1.70.01.71.70.0
Earnings & Valuation Score1.91.32.51.93.1
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyHold
Consensus Price Target$173.33N/A$627.09$214.25$47.83
% Upside from Price Target0.06% upsideN/A7.25% upside1.87% upside9.73% upside
Trade Information
Market Cap$36.09 billion$34.62 billion$46.27 billion$17.95 billion$19.16 billion
Beta1.340.281.680.590.7
Average Volume1,203,73795,694620,943634,566495,326
Sales & Book Value
Annual Revenue$7.98 billion$2.76 billion$2.41 billion$3.03 billion$5.14 billion
Price / Sales4.5212.5319.235.923.73
Cashflow$16.02 per share$0.31 per share$6.41 per share$8.69 per share$3.22 per share
Price / Cash10.8152.4791.2924.2113.55
Book Value$60.25 per share$0.48 per share$17.08 per share$40.17 per share$11.76 per share
Price / Book2.8833.4034.235.243.71
Profitability
Net Income$1.13 billion$585.21 million$442.78 million$407.61 million$600 million
EPS$7.87$0.30$4.96$5.64$2.04
Trailing P/E Ratio1,082.7657.2526.6042.6621.37
Forward P/E Ratio21.9344.5382.1230.6622.59
P/E Growth4.32N/A4.07N/A4.91
Net Margins0.52%21.62%76.00%13.97%N/A
Return on Equity (ROE)10.07%69.30%68.99%14.44%N/A
Return on Assets (ROA)4.93%33.77%46.64%9.32%N/A
Dividend
Annual Payout$0.96$0.22N/A$1.60$0.90
Dividend Yield0.55%1.37%N/A0.76%2.06%
Three-Year Dividend GrowthN/AN/AN/A30.51%102.70%
Payout Ratio12.20%73.33%N/A28.37%44.12%
Years of Consecutive Dividend Growth1 YearsN/AN/A15 Years1 Years
Debt
Debt-to-Equity Ratio0.67%0.02%N/A0.28%0.50%
Current Ratio2.18%1.29%1.31%2.64%2.18%
Quick Ratio1.02%0.90%1.20%2.00%1.04%
Ownership Information
Institutional Ownership Percentage87.17%0.10%85.84%90.01%8.91%
Insider Ownership Percentage0.44%N/A1.20%1.20%1.00%
Miscellaneous
Employees19,90012,50018,07013,00017,914
Shares Outstanding208.32 million2.16 billion79.14 million85.35 million439.49 million
Next Earnings Date8/3/2021 (Estimated)N/A7/28/2021 (Estimated)5/18/2021 (Confirmed)N/A
OptionableOptionableNot OptionableOptionableOptionableOptionable
SourceHeadline
Smith & Nephew (NYSE:SNN) Price Target Raised to $55.00Smith & Nephew (NYSE:SNN) Price Target Raised to $55.00
americanbankingnews.com - May 6 at 2:14 PM
Smith & Nephew (NYSE:SNN) Given Neutral Rating at Credit Suisse GroupSmith & Nephew (NYSE:SNN) Given Neutral Rating at Credit Suisse Group
americanbankingnews.com - May 4 at 5:18 PM
Berenberg Bank Reiterates Buy Rating for Smith & Nephew (NYSE:SNN)Berenberg Bank Reiterates Buy Rating for Smith & Nephew (NYSE:SNN)
americanbankingnews.com - May 4 at 5:18 PM
Smith & Nephews (SNN) "Overweight" Rating Reiterated at BarclaysSmith & Nephew's (SNN) "Overweight" Rating Reiterated at Barclays
americanbankingnews.com - April 30 at 4:44 PM
Smith & Nephews (SNN) Overweight Rating Reaffirmed at BarclaysSmith & Nephew's (SNN) Overweight Rating Reaffirmed at Barclays
americanbankingnews.com - April 30 at 4:44 PM
Smith & Nephew (NYSE:SNN) Rating Reiterated by BarclaysSmith & Nephew (NYSE:SNN) Rating Reiterated by Barclays
marketbeat.com - April 30 at 4:40 PM
Canaccord Genuity Increases Smith & Nephew (NYSE:SNN) Price Target to $55.00Canaccord Genuity Increases Smith & Nephew (NYSE:SNN) Price Target to $55.00
americanbankingnews.com - April 30 at 10:24 AM
Smith & Nephew (NYSE:SNN) Shares Gap Up to $41.77Smith & Nephew (NYSE:SNN) Shares Gap Up to $41.77
americanbankingnews.com - April 29 at 2:28 PM
Smith & Nephew (NYSE:SNN) Sees Large Volume IncreaseSmith & Nephew (NYSE:SNN) Sees Large Volume Increase
americanbankingnews.com - April 23 at 2:18 PM
9 medical devices you should keep an eye out for in 20219 medical devices you should keep an eye out for in 2021
medicaldesignandoutsourcing.com - April 16 at 2:55 PM
Bullish Two Hundred Day Moving Average Cross - SNNBullish Two Hundred Day Moving Average Cross - SNN
nasdaq.com - April 16 at 2:55 PM
Investors Purchase Large Volume of Smith & Nephew Call Options (NYSE:SNN)Investors Purchase Large Volume of Smith & Nephew Call Options (NYSE:SNN)
americanbankingnews.com - April 16 at 12:58 AM
Smith+Nephew: Randomized Clinical Trial Shows Benefit Of LEAF Patient Monitoring SystemSmith+Nephew: Randomized Clinical Trial Shows Benefit Of LEAF Patient Monitoring System
nasdaq.com - April 13 at 10:56 AM
Smith & Nephew PLC Stock Shows Every Sign Of Being Fairly ValuedSmith & Nephew PLC Stock Shows Every Sign Of Being Fairly Valued
finance.yahoo.com - April 2 at 1:27 PM
How Does Smith & Nephews Debt Look?How Does Smith & Nephew's Debt Look?
finance.yahoo.com - March 15 at 12:42 PM
UPDATE 1-U.S. Supreme Court questions patent tribunals constitutionalityUPDATE 1-U.S. Supreme Court questions patent tribunal's constitutionality
finance.yahoo.com - March 1 at 3:32 PM
Berenberg lowers target price on Smith & NephewBerenberg lowers target price on Smith & Nephew
lse.co.uk - February 22 at 2:11 PM
MARKET REPORT: Cancelled surgeries bring pain to Smith & NephewMARKET REPORT: Cancelled surgeries bring pain to Smith & Nephew
msn.com - February 18 at 6:57 PM
Medical equipment firm Smith & Nephews profits hit as hospitals postpone surgeries to treat Covid patientsMedical equipment firm Smith & Nephew's profits hit as hospitals postpone surgeries to treat Covid patients
msn.com - February 18 at 8:56 AM
John Ma joins Smith+Nephews Board as NEDJohn Ma joins Smith+Nephew's Board as NED
sharecast.com - February 11 at 10:22 PM
Smith & Nephew Plc - John Ma joins Smith+Nephews Board as NEDSmith & Nephew Plc - John Ma joins Smith+Nephew's Board as NED
proactiveinvestors.co.uk - February 10 at 8:21 AM
Integra (IART) to Buy ACell, Expand Regenerative CapabilityIntegra (IART) to Buy ACell, Expand Regenerative Capability
nasdaq.com - December 29 at 1:34 PM
Is SNN A Good Stock To Buy Now?Is SNN A Good Stock To Buy Now?
finance.yahoo.com - December 10 at 8:26 PM
New data shows Smith+Nephews NOVOSTITCH™ Meniscal Repair Systems achieve 82.6% success rate for difficult to repair¹ horizontal cleavage tears at two years follow-upNew data shows Smith+Nephew's NOVOSTITCH™ Meniscal Repair Systems achieve 82.6% success rate for difficult to repair¹ horizontal cleavage tears at two years follow-up
finance.yahoo.com - November 17 at 8:08 AM
There’s no need to share Soros’s pain with Smith & NephewThere’s no need to share Soros’s pain with Smith & Nephew
thetimes.co.uk - November 12 at 5:17 AM
Smith & Nephew Holds The Line, But So Does Our ThesisSmith & Nephew Holds The Line, But So Does Our Thesis
seekingalpha.com - November 9 at 12:29 PM
DateCompanyBrokerageAction
5/5/2021Zimmer BiometTruist SecuritiesBoost Price Target
5/5/2021Zimmer BiometCanaccord GenuityBoost Price Target
5/5/2021Zimmer BiometRaymond JamesBoost Price Target
5/5/2021Zimmer BiometSVB LeerinkBoost Price Target
5/5/2021Zimmer BiometOppenheimerBoost Price Target
4/15/2021Zimmer BiometNorthland SecuritiesUpgrade
3/8/2021Zimmer BiometWells Fargo & CompanyBoost Price Target
2/8/2021Zimmer BiometMorgan StanleyBoost Price Target
2/8/2021Zimmer BiometDeutsche Bank AktiengesellschaftBoost Price Target
2/5/2021Zimmer BiometNeedham & Company LLCBoost Price Target
2/5/2021Zimmer BiometPiper SandlerBoost Price Target
1/27/2021Zimmer BiometJMP SecuritiesBoost Price Target
1/25/2021Zimmer BiometBTIG ResearchBoost Price Target
1/6/2021Zimmer BiometTruist FinancialBoost Price Target
1/4/2021Zimmer BiometEvercore ISIUpgrade
12/24/2020Zimmer BiometArgusBoost Price Target
3/9/2021Coloplast A/SCommerzbankUpgrade
3/8/2021Coloplast A/SBarclaysUpgrade
2/9/2021Coloplast A/SJPMorgan Chase & Co.Reiterated Rating
1/20/2021Coloplast A/SBerenberg BankUpgrade
9/23/2020Coloplast A/SJefferies Financial GroupUpgrade
8/11/2020Coloplast A/SNordea Equity ResearchDowngrade
5/5/2021Align TechnologyCredit Suisse GroupBoost Price Target
5/5/2021Align TechnologyStifel NicolausBoost Price Target
4/29/2021Align TechnologyRobert W. BairdBoost Price Target
11/24/2020Align TechnologyThe Goldman Sachs GroupBoost Price Target
3/17/2021STERISKeyCorpBoost Price Target
10/7/2020STERISStephensBoost Price Target
2/12/2020STERISNorthcoast ResearchReiterated Rating
12/6/2018STERISSidotiBoost Price Target
12/18/2020Smith & NephewSanford C. BernsteinUpgrade
7/29/2020Smith & NephewBank of AmericaUpgrade
(Data available from 5/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.